GLP-1 Medicines: The Weight-Loss Revolution Has Entered Its Second Chapter
GLP-1 medicines have moved from being a specialist diabetes treatment to one of the most talked-about medical stories in the world. Drugs in this family, including semaglutide and tirzepatide, are changing how doctors think about obesity, diabetes and several conditions linked to excess weight. The most interesting story, however, is no longer simply “How much weight can someone lose?” The bigger question is: what happens to the rest of the body when these medicines change appetite, blood sugar, body fat and cardiovascular risk? GLP-1 stands for glucagon-like peptide-1, a hormone involved in appetite, digestion and blood-sugar regulation. Some modern medicines mimic this hormone or act on related pathways. In simple